当前位置: X-MOL 学术Bipolar Disord. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Long-term lithium therapy and risk of chronic kidney disease in bipolar disorder: A historical cohort study
Bipolar Disorders ( IF 5.4 ) Pub Date : 2021-02-06 , DOI: 10.1111/bdi.13052
Mehak Pahwa 1 , Boney Joseph 1, 2 , Nicolas A Nunez 1 , Gregory D Jenkins 3 , Colin L Colby 3 , Kianoush B Kashani 4 , Marin Veldic 1 , Katherine M Moore 1 , Hannah K Betcher 1 , Aysegul Ozerdem 1 , Alfredo B Cuellar-Barboza 1, 5 , Susan L McElroy 6 , Joanna M Biernacka 1, 3 , Mark A Frye 1 , Balwinder Singh 1
Affiliation  

Long-term lithium therapy (LTLT) has been associated with kidney insufficiency in bipolar disorder (BD). We aimed to investigate the risk factors of chronic kidney disease (CKD) development and progression among BD patients receiving LTLT.

中文翻译:

双相情感障碍患者的长期锂治疗和慢性肾病风险:一项历史队列研究

长期锂疗法 (LTLT) 与双相情感障碍 (BD) 中的肾功能不全有关。我们旨在调查接受 LTLT 的 BD 患者中慢性肾脏病 (CKD) 发展和进展的危险因素。
更新日期:2021-02-06
down
wechat
bug